Faron Pharmaceuticals Oy (LON:FARN) Share Price Crosses Below 50 Day Moving Average – Here’s What Happened
by Doug Wharley · The Cerbat GemFaron Pharmaceuticals Oy (LON:FARN – Get Free Report)’s stock price crossed below its 50-day moving average during trading on Tuesday . The stock has a 50-day moving average of GBX 42.87 and traded as low as GBX 40. Faron Pharmaceuticals Oy shares last traded at GBX 40.08, with a volume of 45,991 shares changing hands.
Faron Pharmaceuticals Oy Stock Performance
The firm’s fifty day moving average price is GBX 42.82 and its 200-day moving average price is GBX 74.19. The company has a current ratio of 0.84, a quick ratio of 1.09 and a debt-to-equity ratio of -133.35. The company has a market cap of £83.79 million, a P/E ratio of -1.87 and a beta of 1.12.
About Faron Pharmaceuticals Oy
Faron (AIM: FARN, First North: FARON) is a clinical stage biopharmaceutical company developing novel treatments for medical conditions with significant unmet needs. The Company currently has a pipeline based on the receptors involved in regulation of immune response in oncology and organ damage. Clevegen (bexmarilimab), its investigative precision immunotherapy, is a novel anti-Clever-1 antibody with the ability to switch immune suppression to immune activation in various conditions, with potential across oncology, infectious disease and vaccine development.
Featured Articles
- Five stocks we like better than Faron Pharmaceuticals Oy
- Why Abbott Laboratories Stock Is Suddenly Winning Back Wall Street
- Revving Up Returns: Big Banks Race Through the Rate Plateau
- Why Uber’s Biggest Deal Yet Could Unlock Its Next Growth Phase
- Why Microsoft Is Playing a Different AI Game Than Big Tech—and Cash Flow Is the Test